alexa
Reach Us +44-1904-929220
Study of TNF-and#945; Polymorphism (308G/A) and the Role of NF-and#954;B as an Novel Marker of Severity of Atherosclerosis: A Pilot Study in Indian Population
ISSN-2155-9929
Journal of Molecular Biomarkers & Diagnosis

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Study of TNF-α Polymorphism (308G/A) and the Role of NF-κB as an Novel Marker of Severity of Atherosclerosis: A Pilot Study in Indian Population

Arpita Suri1*, Ritu Singh1, Sanjay Tyagi2 and Jayashree Bhattacharjee3

1Department of Biochemistry, Lady Hardinge Medical College, New Delhi, India

2Maulana Azad Medical College, Bahadurshah Zafar Marg, New Delhi, India

3Safdarjung Hospital and Vardhaman Mahavir Medical College, New Delhi, India

*Corresponding Author:
Arpita Suri
Department of biochemistry
Lady Hardinge Medical College
New Delhi, India
Tel: +919999718289
E-mail: [email protected]

Received date: April 21, 2015; Accepted date: May 24, 2016; Published date: May 26, 2016

Citation: Suri A, Singh R, Tyagi S, Bhattacharjee J (2016) Study of TNF-α Polymorphism (308G/A) and the Role of NF-κB as an Novel Marker of Severity of Atherosclerosis: A Pilot Study in Indian Population. J Mol Biomark Diagn 7:287. doi:10.4172/2155-9929.1000287

Copyright: © 2016 Suri A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Molecular Biomarkers & Diagnosis

Abstract

Background: Biallelic polymorphism of A/G variation at position 308 in the promoter region of TNF-α gene is an important genetic factor causing high TNF-α transcription which could influence the clinical outcome of atherosclerosis. Studies have also implicated the role of NF-κB in atherogenesis by regulating genes involved in the inflammatory response and insulin sensitivity.

Material and Method: 50 cases of angiographically significant atherosclerosis (>50% obstruction in coronary arteries) and 50 age, sex, BMI matched patients with insignificant atherosclerosis (>50% obstruction) on angiography were selected from GB Pant Hospital. Polymorphism was studied by amplifying DNA using PCR and amplified segments were digested by restriction enzyme Nco-I and followed by RFLP. Serum NF-κB, TNF-α levels were estimated by sandwich ELISA.

Results: The mean serum NF-κB and TNF-α levels were significantly (p=0.04, 0.000 respectively) raised in cases as compared to controls. Upon binomial logistic regression analysis, NF-κB emerged as the best predictor of severity of atherosclerosis (Odds ratio=27) among other markers. Our results showed no intergenotypic variation of 308-G/A polymorphism of the TNF-α gene between cases and controls.

Conclusion: Our study establishes NF-κB as an emerging biomarker of severity of atherosclerosis in Indian population. No intergenotypic variation between cases and controls indicates that significantly high levels of TNF-α in the cases is attributed to cause other than polymorphism in Indian population. High prevalence of chronic low grade inflammation in population could be postulated as the possible cause.

Introduction

Over the past few decades, the management of atherosclerosis mainly included reduction of Low Density Lipoprotein-cholesterol by lipid lowering drugs like statins. In spite of success in lowering LDL the epidemic of Ischemic Heart Disease has continued to surge. The focus of research has therefore justifiably shifted from dyslipidemia to inflammatory processes. Studies show inflammatory processes might have a key role in the initiation and progression of atherosclerosis.

TNF-α is a proinflammatory cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. It is produced chiefly by activated macrophages, endothelial cells and adipose tissue. It is chemoattractant for neutrophils and increases the expression of cell adhesion molecules on endothelial cells [1]. In liver, it causes insulin resistance by serine phosphorylation of insulin receptor substrate (IRS-1) which further predisposes to atherosclerosis [2].

Because genetic traits contribute significantly to the global risk of ischaemic heart disease (IHD) [3], a number of studies have now addressed the hypothesis that variations in the genetics of the inflammatory system may increase the risk of disease. Differences in the genetic regulation of inflammatory processes might explain why some people develop a greater inflammatory response predisposing them to increased cardiovascular risk [3].

TNF-α POLYMORPHISM-TNF-α gene is located on chromosome 6p21.3.It codes for a 157 aminoacid polypeptide processed from 233 amino acid precursors. The biallelic polymorphism of A/G variation at position 308 in the promoter region of TNF-alpha gene is an important genetic factor predisposing to inflammation and insulin resistance [4]. Previous studies indicate that rare allele A might be associated with high TNF-α transcription causing greater insulin resistance which could influence the clinical outcome of atherosclerosis [5,6].

Rel or NF-kappaB (NF-kB) proteins comprise a family of structurally-related eukaryotic transcription factors that are involved in the immune and inflammatory responses and are implicated in number of disease states, including heart disease.

NF-κB regulates host inflammatory and immune responses [7] by increasing the expression of specific cellular genes encoding at least 27 different cytokines and chemokines, receptors involved in immune recognition such as members of the MHC, proteins involved in antigen presentation and receptors required for neutrophil adhesion and migration [8]. NF-κB regulation of genes involved in the inflammatory response likely plays an important role in the initiation and progression of atherosclerosis.

Material and Methods

It was Descriptive Observational case control study conducted in the Department of Biochemistry in Lady Hardinge Medical College in collaboration with the Department of Cardiology, GB Pant Hospital after approval by the ethical committee of LHMC, New Delhi. We enrolled 50 non diabetic cases diagnosed with angiographically significant atherosclerosis (>50% obstruction in coronary artery) and 50 age and sex matched controls with insignificant atherosclerosis (<50% obstruction) on angiography after informed written consent. The patients on statins were excluded from the cases. The study was approved by institutional ethical committee of LHMC.

Venous blood sample was collected from the subjects under sterile condition after overnight fasting of 8-12 hrs. The plasma samples were stored at -20°C till subsequent analysis for TNF-α and NF-κB. Special investigation like TNF-α was estimated by ELISA using kit from Diaclone Research (France) while NF-κB was estimated using a kit from Biomedical Medical assay (Beijing, China).

To determine the TNF-α -308 G/A gene polymorphism, we extracted genomic DNA from the leukocyte of whole blood sample using the QI Amp DNA Blood Kit (Qiagen, Hilden, Germany). The extracted genomic DNA was then amplified by PCR using following primers:

Forward Primer: 5’-AGGCAATAGGTTTTGAGGGCCAT-3’ (23 bp)

Reverse Primer: 5’-TCCTCCCTGCTCCGATTCCG-3’ (20 bp)PCR was carried out in a final volume of 25 μl. The final concentration of reaction mixture had 1.5 mM MgCl2, 0.4 mM each dNTPs, 0.4 μl of each primer, 5 U of Taq Polymerase and 2 μl of genomic DNA. PCR program comprised of Initial Denaturation 95 for 5 min, followed by Cycle Denaturation 94 for 30 sec, Cycle Annealing 60 for 40 sec, Cycle Extension 72 for 30 sec each for 32 cycles and then Final Extension at 72 for 7 min.

The resulting PCR product (10 μl) was digested with 5 units of NcoI restriction enzyme at 37 overnight and electrophoresed on 10% nondenaturing polyacrylamide gel. Due to 308G/A polymorphism, there are three genotypes, GG (wild type), GA (heterozygous) and AA (mutant type).

Statistical Analysis

It was done by using SPSS (statistical package for social sciences) 20 version. All the data was expressed as mean ± SE of mean. The p value of <0.001 was considered highly significant.

The data obtained was compared between two groups by student ttest. Binomial regression analysis was applied to establish relationship between dependent and independent variables.

Results

In the study the mean plasma TNF-α level in the study group (cases) was 362.20 ± 33.43 pg/ml and in the control group was 186.94 ± 25.07 pg/ml. The difference between the two was statistically significant (p value=0.000*) (Table 1).

Parameter Study Group Mean S.E.M p Value
TNF-α(pg/ml) Case 362.20 33.43 0.000*
Control 186.94 25.07
NF-κB(ng/ml) Case 0.33 0.014 0.050*
Control 0.29 0.015

Table 1: Parameters in study population.

The mean serum NF-κB level in the study group (cases) was 0.33 ± 0.10 and in the control group was 0.29 ± 0.11 ng/ml which was statistically significant (p=0.04) (Table 1). Upon binomial logistic regression analysis, NF-κB emerged as the best predictor of severity of atherosclerosis (Odds Ratio=27) among other markers such as IL-6, Adiponectin, HOMA-IR and TNF-α. The RFLP revealed only wild type G/G homozygous genotype in 50 cases and 50 controls.

Discussion

Worldwide there are very few clinical studies evaluating the role of NK-κB in atherosclerosis. In 2001, Tak et al. [9] proposed that nuclear factor-κB (NF-κB) is an important regulator of inflammation and plays a key role in inflammatory diseases. In 2004 Jian Jun et al. [10] reported that NF-κB were raised in cases as compared to controls (p<0.01) in Chinese patients with stable angina. In support of this Gerondakis et al. [7] proposed that NF-κB increases the expression of specific cellular genes encoding for cytokines, major histocompatibility complex (MHC), proteins for antigen presentation, and receptors for neutrophil adhesion and migration [7], thus playing a vital role in intiation and progression of atherosclerosis.

In the study the mean plasma TNF-α level in the study group (cases) was 362.20 ± 33.43 pg/ml and in the control group was 186.94 ± 25.07 pg/ml. The difference between the two was statistically significant (p value=0.000*) (Table 1). With the increasing recognition that inflammatory mechanisms play a key role in the pathogenesis of atherosclerosis [11], attention has been focused on the role of tumour necrosis factor-α in patients at risk for the development of atherosclerosis. Our findings are in accordance to Ross and Skoog et al. [11,12] who have also implicated TNF-α as an important contributor to the development of atherosclerotic lesions by promoting the expression of adhesion molecules on endothelial cells and initiating inflammatory cascade inside the arterial wall.

In 2008, Kosmala et al. [13] also observed significant rise in TNF levels in stable IHD cases. This signifies that TNF-α is an important novel marker of inflammation and has a potential in identifying individuals at high cardiovascular risk.

In my study only wild type G/G homozygous genotype were found in 50 cases and 50 controls. No G/A heterozygous or A/A homozygous were found. Higuchi et al. [14] in a study on 575 Japanese found allele frequency of 98.3% of -308G and 1.7% of 308A. Chu et al. [15] examined 535 Chinese individuals with CHD, out of which 102 heterozygotes for mutant allele A were detected and 5 homozygotes.

Therefore inability to find polymorphism could be attributed to relatively low frequency of A allele as supported by the Chinese studies. In 2011, Lal et al. [16] did the similar 308 G/A promoter region polymorphism of TNF-α gene study in patients with metabolic syndrome in which only 3 heterozygote for mutant allele A and 1 homozygote in 50 cases and 50 controls, the allele frequency being quite similar to that observed in our study. It is possible that the significantly high levels of TNF-α in the cases is attributed to low grade inflammation rather than genetic polymorphism in Indian population.

Our study also shows G allele homozygosity is neither associated with severity of atherosclerosis nor increase in TNF-α levels. Further studies on a larger sample size are required for in depth evaluation role of TNF-α polymorphism in Atheroslerosis.

Conclusion

Thus, we postulate that, an inflammatory pathology has an important role in atherosclerosis and it can be assessed by biomarkers TNF-α. Hence markers of micro-inflammation can indicate the atherosclerotic risk in an individual. The novel marker NF-κB which is a mediator of inflammation and insulin resistance pathways also has an important role in IHD. We could not find any polymorphism in genotypes of cases and controls as sample size could be a limiting factor in our study.

So, these findings suggest that inflammation promotes atherogenesis in an individual predisposed to cardiovascular risk. This indicates that these novel biomarkers of inflammation need further evaluation in larger sample size for better non-invasive diagnosis of atherosclerosis.

Acknowledgement

It is my immense pleasure and privilege to express my sincere feelings of deep gratitude and debt towards my teacher and supervisor Dr. Ritu Singh, Professor, Department of Biochemistry, Lady Hardinge Medical College, for her expert guidance and masterly supervision throughout the study. It was with her keen interest, inspiration, guidance, intelligent criticism, vital suggestion and scholarly approach that I was able to complete this work.

With a deep sense of gratitude, I express my most sincere thanks to Dr. Sanjay Tyagi, Dean, MAMC and associated Lok nayak jaiprakash hospital and Dr. Jayashree Bhattacharjee, Principal, VMMC and Safdarjung Hospital, my co-supervisors, for their supportive attitude and invaluable guidance, which helped me to finish this work.

References

  1. Kurokouchi K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, et al. (1998) TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 13: 1290-1299.
  2. Feinstein R, Kannety H, Papa MZ, Lunenfield B, Karasik A (1993) Tumour Necrosis Factor-α suppresses Insulin-induced Tyrosine Phosphorylation of Insulin Receptors and Its substrates. J Biol Chem 268: 26055-26058.
  3. Woods A, Brull DJ, Humphries SE, Montgomery HE (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21: 1574-1583.
  4. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, et al. (2003) Apolymorphismin the promoter of tumour necrosis factor-α gene(-308) is associated with coronary heart disease in Type 2 diabetic patients. Atherosclerosis 167: 257-264.
  5. Fernandez-Real JM, Guitierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, et al. (1997) The TNF-α Nco-1 polymorpism influences the relationship among insulin resistance,percent body fat and increased serum leptin levels. Diabetes 46: 1468-1472.
  6. Hoffstedt J, Eriksson P, Hellstorm L, Rossner S (2000) Excessive fat accumulation is associated with TNF-α -308 G/A polymorphism in women but not in men. Diabetologia 43: 117-1120.
  7. Gerondakis S, Grumont R, Rourke I, Grossmann M (1998) The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Current opinion in immunology. 10: 353-359.
  8. Pahl HL (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866.
  9. TakPP,FiresteinGS (2001)NF-kappaB:akeyroleininflammatory diseases. J Clin Invest 107: 7-11.
  10. Jian JJ, Fang CH, Chen MZ, Chen X (2004) Activation of Nuclear Factor-κB and Correlation with Elevated Plasma C-reactive Protein in Patients with Unstable Angina. Heart, Lung and Circulation 13: 173-178.
  11. Ross R (1999) Atherosclerosis--an inflammatory disease. N Engl J Med 340: 115-126.
  12. Skoog T, Dichtl W, Boquist S, Skoglund-Andersson C, Carpe F, et al. (2002)Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J23: 376-383.
  13. Kosmala W,Derzhko R,Kosmala MP, Orda A, Mazurek W (2008) Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 19: 375-382.
  14. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, et al. (1998) Polymorphism of the 5’flanking region of the human tumor necrosis factor (TNF-α) gene in Japanese. Tissue Antigens51: 605-612.
  15. Chu H, Yang J, MiS, Bhuyan SS, Li J, et al. (2012) Tumor necrosis factor-alpha G-308 A polymorphism and risk of coronary heart disease and myocardial infarction: A case-control study and meta-analysis. J Cardiovasc Dis Res 3: 84-90.
  16. Lal S, Bhatnagar MK, Bhattarcharjee J (2011) The study of pro-inflammatory cytokines and TNF-α gene promoter region polymorphism in metabolic syndrome. University of Delhi, New Delhi.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 9097
  • [From(publication date):
    July-2016 - Jun 18, 2019]
  • Breakdown by view type
  • HTML page views : 8977
  • PDF downloads : 120
Top